Wayne Kuang, MD; and Matt T. Rosenberg, MD, discuss how overactive bladder presents with distinct pathophysiological mechanisms between genders, requires different diagnostic approaches when distinguishing from benign prostatic hyperplasia in men, impacts quality of life in older adults, benefits from early primary care intervention, and necessitates improved patient advocacy and educational initiatives for optimal management outcomes.

Panelists explore challenges in identification of intermediate risk patients and emphasize importance of risk stratification to improve outcomes in regards to NMIBC.

Panelists discuss how managing overactive bladder in older adults requires a holistic approach that integrates treatment of comorbidities, emerging therapeutic options, and quality-of-life considerations to optimize patient outcomes.

Experts discuss overactive bladder and the impacts on quality of life, distinguishing OAB from BPH, and how a delayed diagnosis can worsen symptoms.

In this episode of Speaking of Urology®, former Major League Baseball (MLB) player, Dave Winfield, shares lessons he’s learned throughout his professional baseball career and his work in philanthropy. Winfield delivered a keynote presentation at this year’s LUGPA Annual Meeting titled, “Leadership Lessons Learned from Baseball, Business and Philanthropy.”

In this episode of Speaking of Urology®, Juan J. Andino, MD, MBA, speaks with Robert E. Brannigan, MD on the recent amendment to the American Urological Association (AUA) guideline on male infertility. This discussion originally took place during a live X (formerly Twitter) Spaces event held by Urology Times®.

In this episode of Speaking of Urology®, Ashley G. Winter, MD, discusses the use of vaginal estrogen. Winter is a urologist and sexual medicine expert in Los Angeles, California.

In this episode of Speaking of Urology®, Eugene Rhee, MD, MBA, and Logan Galansky, MD, discuss key topics in health policy for urology and recap the American Urological Association’s (AUA) recent Annual Urology Advocacy Summit, which took place from February 26-28 in Washington DC.

In this interview, Adam B. Murphy, MD, MBA, MSCI, discusses the need to increase diversity in clinical trials, specifically focusing on studies in prostate cancer.